Different antibiotics and chemotherapeutics were tested for therapeutic efficacy in rabbits, in an experimental model using a Pasteurella multocida strain which causes hyperacute septicaemia in this animal species. Only enro-f1oxacin, administered in the drinking water at a concentration of 50-100 mg/I cured the rabbits, provided that a daily intake of 5 mg/kg body weight was achieved. The other drugs tested (tetracycline, spiramycin, erythromycin and a combination of sulfamerazine with trimethoprim), at doses recommended for rabbits, showed little or no activity at all, with the exception of chloramphenicol, which was only partially effective.
with similar diseases in other animal species, but evidence for therapeutic activity is lacking. Therefore, we studied the effect of different antibiotics and chemotherapeutics, in an experimental model using a P. multocida strain which causes hyperacute septicaemia and rapid death in rabbits. Few data on plasma antibiotic concentrations are available in rabbits (Guillot et al. , 1988; Percy & Black, 1988) and it is not known whether or not these predict accurately therapeutic outcome in this animal species.
The choice of antibiotics in rabbits is restricted, because many disturb the intestinal flora, resulting in clostridial enterotoxaemia (Morisse, 1976; Borriello & Carman, 1983 ). In the experiments described below, only antibiotics and chemotherapeutics which are frequently prescribed for rabbits, were tested at their usual oral doses. Oral administration of drugs is the most practical way of treatment in large groups of animals.
Materials and methods

Rabbits
All rabbits belonged to the Belgian Silver breed (a local breed related to Argente de Champagne), and were purchased from a closed colony, which had been free from P. multocida as well as from enteropathogenic E. coli for at least 12years. This colony had shown a very low mortality rate (under 30/0) over the years. During this period no P. multocida nor enteropathogenic E. coli biotypes were recovered from nasal resp. rectal swabs which were taken at different occasions from breeders and/or young animals; neither were the pathogens isolated at routine necropsies of animals which died in this farm. The colony was, however, infected with Bordetella bronchiseptica and Eimeria spp., which apparently did not cause any mortality or overt disease. All experimental animals were weaned, and arrived one week prior to the start of the experiment at the laboratory. During their acclimatization period and during the experiments they were housed individually in metal cages with a perforated bottom, and pellets and drinking water were supplied in individual feeders and bottles. They were fed with a commercially available pelleted rabbit chow, supplemented with 66 p.p.m. robenidine as a coccidiostatic (Debaillie voeders, Roeselare, Belgium). At the start of the experiments, they aged between 6 weeks and 3 months and weighed between 1·200 and 2·850kg.
Infection strain P197 was originally isolated from a rabbit which died from septicaemia. It is a highly virulent A : I P. multocida strain, and has biochemical characteristics different from the common P. multocida strains which occur on the nasal mucosae of rabbits. Its LD50 for mice is less than 10 colony forming units. Its origin and characteristics have been described in earlier papers (Okerman et al., 1979; Okerman & Spanoghe, 1981) . The strain had been preserved in the lyophilized state until needed. Minimal inhibitory concentrations (MICs) of antibacterials against P197, determined according to the American Society of Microbiology Manual of Clinical Microbiology (Washington, 1985) , were as follows: enrofloxacin O' 012 g!ml; chloramphenicol O' 25 g!ml; oxytetracycline O' 12 g!ml. The strain was tested on Isosensitest medium (Oxoid, Basingstoke, England), supplemented with bovine blood, against sulphonarnides, trimethoprim, spiramycin and erythromycin in the agar diffusion technique using antibiotic tablets of Rosco (Taastrup, Denmark). Following the interpretative criteria of the manufacturer, the strain was sensitive.
Experimental design
The rabbits were distributed randomly over seven test groups. The following treatments were tested: 1gil sodium sulphamerazine with 50 mg!l trimethoprim base: 250 mg!l tetracycline HCI:
Okerman et af. 250 mg!l spiramycin base (Suanovil, 50070 spiramycin, Specia); 150 mg!l erythromycin isothiocyanate (Erythrocin W. 10070 erythromycin, Abbott, Brussels, Belgium): 500 mg!l chloramphenicol base; 25 mg!l enrofloxacin (Baytril, 10% oral solution, Bayer, Leverkusen, GFR) and 50 mg!l enrofloxacin. Enrofloxacin at a dose of 100 mg!l was tested on two different occasions. All groups were composed of 6 rabbits, except the chloramphenicol and the enrofloxacin 50 mg!l groups in which 5 animals were tested. All drinking water treatments started 24 h before infection with P. mu/tocida. Chloramphenicol was given during 6 consecutive days to the surviving animals, enrofloxacin during 3 days.
In the other treated groups all rabbits died before the treatments were planned to end. Dosages! kg body weight, listed in the tables, were measured the day before experimental infection, except for the surviving animals, where the mean daily intake was calculated over 3 days.
All animals were infected with approximately 107 c.f.u. of P197, by subcutaneous injection. Untreated controls, 10 in total, were infected with the same dose along with the different treatment groups. Mortalities were recorded for 10 days after experimental infection.
Results
None of the untreated controls survived more than 24 h post infectionem (p.i.); at necropsy they showed the typical gross pathology of the septicaemic form of pasteurellosis and P197 was readily reisolated.
Compared to the days before treatment, drinking water intake was not reduced in the enrofloxacin, tetracycline, sulphamerazine + trimethoprim and spiramycin groups, whereas 3 of 6 erythromycin treated animals drank about 30-40% less than the day before. The other 3 rabbits of this group drank about the same quantities. The chloramphenicol treated animals drank 25-50070less. Drug intakes per kg LW and per day are listed in the table.
Twenty-four hours after the experimental infection, none of the tetracycline, none of the sulphamerazine + trimethoprim and none of the 'Not protected: dead within 24 h p.i.; partially protected: died between 2 and 7 days p.i. or did not recover completely; effectively protected: survived till the end of the experiment.
spiramycin treated animals survived. Five of 6 erythromycin treated and one of 5 chloramphenicol treated animals were also found dead 24 h after the experimental infection. The only surviving erythromycin treated rabbit died on the second day after infection. One of the 3 surviving rabbits of the chloramphenicol group died 2 days p.i. and one on the seventh day p.i., one day after medication was withdrawn. The others survived till the end of the experiment. Only one of the 6 rabbits belonging to the group receiving 25 p.p.m. enrofloxacin in the drinking water survived till 10 days p.i. but it was in a bad condition at that moment and necropsy revealed the presence of a large subcutaneous abscess at the injection site. Two rabbits of 5 which received 50 mg/I enrofloxacin survived and were in good health at the end of the experiment, as well as 11 of the 12 rabbits treated with 100mg/I enrofloxacin (Table 1) . During the whole period following infection, they ate and drank normally.
All the animals whose intake of enrofloxacin was higher than 5 mg/kg body weight survived till 10 days p.i., 8 days after medication was withdrawn. Only one of the rabbits which consumed lower doses of enrofloxacin survived, but this one was not in good health at the end of the experiment.
Discussion
The highly virulent P. multocida strain PI97 was chosen because PI97 is fully sensitive to the most common antibiotics prescribed for rabbits. We considered this model appropriate for septicaemia with Gram-negative bacteria in this animal species as, at the infection dose used in our trials, the strain killed all untreated controls within 24 h. The infection dose was high, but test groups were treated 24 h in advance, thus allowing to obtain, if possible, an adequate blood level which should inhibit septicaemia. The high infection dose was chosen in order to find the most effective treatment.
An important fact contributing to the efficacy of treatments administered via the drinking water is the taste of the treatment compound. In our experiments the animals drank less water when it was supplemented with chloramphenicol or erythromycin, and this may have influenced the outcome of the challenge result. Although tetracyclin was not rejected, in previous unpublished experiments we observed that other rabbit strains refused to drink tetracyclin supplemented water. It is not known whether the addition of sweet compounds, e.g. sugar will influence the intake of medicated drinking water, but in practice this problem can be solved by giving medicated feed rather than supplementing the drinking water.
The differences between in vitro and in vivo activities of the substances tested were striking. The challenge strain was sensitive in vitro to all antibiotics used but only enrofloxacin appeared to be effective at dosages which were not rejected and well supported by the animals; therefore different dosages were tested with this antibiotic. It was found that the dose necessary for protection was high: over 5 mg/kg, preferably 10 mg/kg body weight (Table 1) .
Nearly nothing is known on resorption from the intestinal tract and on pharmacokinetics after oral administration to rabbits of any of the antibiotics tested, except chloramphenicol and tetracycline. Guillot et 01. (1988) found that a single dose of 50 mg chloramphenicol per kg body weight, administered by gavage, did not attain plasma levels which are considered therapeutically sufficient. Only trace levels of tetracycline were achieved in the blood of rabbits which had received high doses of tetracycline hydrochloride (800 and 1600 mg/I drinking water) (Percy & Black, 1988) . Lagomorphs have a complicated digestive physiology, and have been compared in some ways to ruminants. Food particles excreted as soft fecal pellets are reingested (Hornicke, 1981) , thus suggesting that recycling and a retard effect can be established, provided that the antibiotic is not inactivated by the intestinal flora. Again, no studies have been conducted to examine if inactivation of antibiotics takes place in rabbits, although the mechanism is important in some other mammals and in birds.
The results obtained with the septicaemic strain P197 cannot be generalized to the other' forms of rabbit pasteurellosis, which are much more common. Spiramycin, which was reported effective against respiratory manifestations of pasteurellosis (Mercier & Laval, 1989) , did not prevent septicaemia with P 197in our experiments. Even enrofloxacin, the most effective antibiotic tested under high challenge conditions, was not able to cure rabbits suffering from snuffles, nor to eliminate or lower the number of P. mu/tocida carriers; only a temporary amelioration of symptoms was achieved (Okerman et al., unpublished observations 
